EverPoint Asset Management’s Amedisys AMED Stock Holding History

EverPoint Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-155,000	Closed	-$7.49M	–	380
2016 Q1	$7.49M	Buy	155,000 +40,000	+35%	+$1.54M	0.15%	172
2015 Q4	$4.52M	Buy	115,000 +65,000	+130%	+$2.6M	0.09%	266
2015 Q3	$1.9M	Buy	+50,000	New	+$2.11M	0.05%	335
2014 Q4	–	Sell	-500,000	Closed	-$10.1M	–	451
2014 Q3	$10.1M	Buy	+500,000	New	+$9.65M	0.23%	145

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EverPoint Asset Management's AMED Position: Q2 2016 in Review

EverPoint Asset Management sold out of Amedisys (AMED) in Q2 2016, closing a stake of 155,000 shares — an estimated $7.49M sold.

EverPoint Asset Management first reported a position in AMED in Q3 2014 and held it in 4 quarters. The position peaked at $10.1M in Q3 2014. 168 funds tracked by Wall St. Rank hold AMED as of Q2 2016.

EverPoint Asset Management reported no remaining Amedisys position as of Q2 2016 after selling out during the quarter.
EverPoint Asset Management sold 155,000 Amedisys shares in Q2 2016, an estimated $7.49M.
EverPoint Asset Management first reported a position in Amedisys in Q3 2014 and held it in 4 quarters.
EverPoint Asset Management's Amedisys position peaked at $10.1M in Q3 2014.
168 funds tracked by Wall St. Rank held Amedisys as of Q2 2016.

Based on EverPoint Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.